Balyasny Asset Management LLC Sarepta Therapeutics, Inc. Call Options Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$124.33 - $156.75 $8.08 Million - $10.2 Million	-65,000 Reduced 52.0%	60,000 $7.49 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $14.2 Million - $20.5 Million	125,000 New	125,000 $19.8 Million
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $6.66 Million - $8.03 Million	-65,000 Reduced 51.22%	61,900 $7.5 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $4.51 Million - $6.66 Million	42,400 Added 50.18%	126,900 $14.5 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $9.93 Million - $13.2 Million	84,500 New	84,500 $11.6 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $921,543 - $1.3 Million	14,700 Added 18.85%	92,700 $6.95 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $9.43 Million - $13.2 Million	-143,000 Reduced 64.71%	78,000 $7.21 Million
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $6.03 Million - $14.1 Million	83,500 Added 60.73%	221,000 $16.5 Million
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $17.3 Million - $24.6 Million	137,500 New	137,500 $23.4 Million
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $8.01 Million - $17.3 Million	-110,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $2.58 Million - $3.49 Million	23,000 Added 26.44%	110,000 $14.3 Million
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $6.29 Million - $8.95 Million	59,000 Added 210.71%	87,000 $10.4 Million
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $8.34 Million - $12.7 Million	-85,700 Reduced 75.37%	28,000 $3.06 Million
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $5.12 Million - $11 Million	-71,300 Reduced 38.54%	113,700 $15 Million
Q1 2018 May 15, 2018	BUY	$54.02 - $82.27 $9.99 Million - $15.2 Million	185,000 New	185,000 $13.7 Million

Others Institutions Holding SRPT

# of Institutions

528

Shares Held

85M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.15 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$700 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$487 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$478 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.79B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account